tbuckley/cabot-search huggingface dataset:
Amer J of Clinical Nutrition, New York
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Racial Disparities in Diabetes Mortality Among Persons Aged 1-19 Years—United States, 1979-2004
Journal: JAMA (2008)

Diabetes is a chronic disease with a U.S. prevalence of 18 cases per 10,000 youths aged <20 years. With proper management and access to care, morbidity and mortality from diabetes are preventable, particularly in the pediatric population. Although diabetes is more common among non-Hispanic white youths, some studies report higher death rates among racial/ethnic minorities and among those in lower socioeconomic strata. In 2004, age-adjusted diabetes death rates for black persons in the United States were approximately twice those for white persons. However, no recent studies on racial disparities that focus specifically on the pediatric population have been conducted. To assess racial disparities in diabetes mortality among youths, CDC analyzed data on deaths with an underlying cause of diabetes among persons aged 1-19 years for the period 1979-2004. This report summarizes the results of that analysis, which determined that, during 1979-2004, diabetes death rates for black youths were approximately twice those for white youths. During 2003-2004, the annual average diabetes death rate per 1 million youths was 2.46 for black youths and 0.91 for white youths. Further study is needed to discern the specific reasons for increased diabetes mortality in black youths. Better identification and management of the disease among youths, especially among black youths, might help decrease racial disparities and prevent deaths from diabetes.
In This Issue/Research Watch/News-in-Brief/News from the IASLC Tobacco Control Committee
Journal: Journal of Thoracic Oncology (2018)

Pleural Mesothelioma (Version 1.1) To address the inaccuracies and inconsistencies in tumor response assessment using the modified RECIST (Response Evaluation Criteria in Solid Tumors) published in 2004 for mesothelioma trials, the proposed modified RECIST 1.1 for mesothelioma incorporated updated guidelines with recommendations from RECIST 1.1, based on published research since modified RECIST, and approaches to address other practical issues.These issues include (1) definition of minimally measurable disease; (2) definition of measurable lesions; (3) acceptable measurement location; (4) non-pleural disease considerations; (5) characterization of nonmeasurable pleural disease; (6) assessment of pathological lymph nodes; (7) establishing progressive disease; and (8) accommodations for bilateral pleural disease.Adoption of the modified RECIST 1.1 guidelines for mesothelioma would standardize the tumor measurement and response assessment across future clinical trials.(p.1012)
Targeting naproxen coupled to human serum albumin to nonparenchymal cells reduces endotoxin-induced mortality in rats with biliary cirrhosis
Authors: C Albrecht
Journal: Hepatology (1997)

Endotoxin is thought to play a major role in cirrhotic liver disease. Cyclo-oxygenase inhibitors were shown to be partially protective against endotoxin but cannot be used in cirrhotic patients because of renal side-effects. We argued that administration of naproxen (NAP) linked to human serum albumin (HSA), which results in specific delivery of NAP to endothelial cells (EC) and Kupffer cells (KC) and exhibited hepatoprotective effects against lipopolysaccharide (LPS) in vitro, could protect cirrhotic rats from LPS toxicity while preserving renal function. The studies were performed in rats rendered cirrhotic by bile duct ligation (BDL); animals received LPS (Escherichia coli, 800 µg/kg) intravenously. Five groups were studied: LPS alone, rats pretreated with a conventional dose of NAP (50 mg/kg), NAP-HSA (22 mg/kg), NAP equimolar to NAP-HSA (1.5 mg/kg), or the HSA carrier. LPS induced significant mortality (55%); this was not affected by equimolar NAP (57%) but accentuated by conventional NAP (88%). In contrast, NAP-HSA provided significant protection (9%; P < .05). After conventional NAP treatment, significant renal toxicity was observed as evidenced by a marked reduction in sodium excretion (LPS vs. NAP-HSA vs. NAP [50 mg/kg] 33 ± 22 vs. 50 ± 39 vs. 4 ± 3 µmol/h; P < .05). Renal prostaglandin E2 (PGE2) excretion was reduced by NAP in all groups, but most markedly at the conventional dosage (LPS vs. NAP-HSA vs. NAP [50 mg/kg] 132 ± 115 vs. 39 ± 19 vs. 9 ± 8 ng/mL; P < .05). Successful targeting was evidenced by a significant hepatic enrichment of NAP in the NAP-HSA group compared with the equimolar untargeted group (30.16 ± 9.33 vs. 1.13 ± 1.95 nmol/g liver). Thus, targeting NAP to EC/KC results in improved survival, higher efficacy, and sparing of renal function in cirrhotic rats.
Nordisk Medicin, Stockholm
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Pediatric Surgery
Authors: W. Hardy Hendren, Craig W. Lillehei
Journal: New England Journal of Medicine (1988)

THERE have been many advances in pediatric surgery since the field was last reviewed in the Journal.1 2 3 Pediatric surgery has become a recognized specialty, with 22 training programs approved by the Residency Review Committee of the American Medical Association. Seventeen of the programs train one resident each year, and five train one every two years. Thus, an average of 20 pediatric surgeons are produced annually in the United States and Canada. The manpower requirements for the specialty have been studied,4 since some specialties are known to have a surplus of practitioners. In 1975, after long consideration,5 the American Board . . .
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Cystatin-C Are Sensitive Markers of Renal Injury in Patients with Multiple Myeloma,
Authors: Evangelos Terpos, Gerasimos-Petros Papassotiriou, Efstathios Kastritis, Maria Gkotzamanidou, Dimitrios Christoulas, Evangelos Eleutherakis-Papaiakovou, Alexandra Margeli, Magdalini Migkou, Maria Gavriatopoulou, Maria Roussou, Ioannis Papassotiriou, Meletios Athanasios Dimopoulos
Journal: Blood (2011)
Front &amp; Back Matter
Authors: A.K. Risch, S. Taeger, J. Brüdern, U. Stangier, Willemijn D. Scholten, Neeltje M. Batelaan, Patricia van Oppen, Johannes H. Smit, Anton J.L.M. van Balkom, Karl Rickels, Bijan Etemad, Moira A. Rynn, Falk W. Lohoff, Laura A. Mandos, Robert Gallop, Richard Balon, Karl Rickels, Elena Tomba, Giovanni Andrea Fava, Allan A. Abbass, Joel M. Town, Denise C. Bernier, Anette Kersting, Ruth Dölemeyer, Yutaka Matsuoka, Daisuke Nishi, Kei Hamazaki, Francesca Venditti, Fiammetta Cosci, Olivia Bernini, Carmen Berrocal, Franz Caspar, Xudong Zhao, Riccardo Dalle Grave, Simona Calugi, Maddalena Conti, Helen Doll, Christopher G. Fairburn, Jana Steinig, Franziska Walter, Kristin Kroker, Katja Baust, Birgit Wagner, Norio Watanabe, Toshi A. Furukawa, Shinji Shimodera, Fujika Katsuki, Hirokazu Fujita, Megumi Sasaki, Yousuke Suga, Kyoko Kakeda, Michael L. Perlis, Emanuela Offidani, Jenny Guidi, Alan N. Simmons, Sonya B. Norman, Andrea D. Spadoni, Irina A. Strigo, Satz Mengensatzproduktion, Druck Reinhardt Druck Basel, Druck Reinhardt Druck Basel
Journal: Psychotherapy and Psychosomatics (2013)
Pharmacotherapy
Journal: JAMA (1998)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The public Service
Journal: JAMA (1901)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Pathology of the Oral Cavity
Journal: JAMA (1942)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Erratum for the Report: “Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells” by W. Qasim, H. Zhan, S. Samarasinghe, S. Adams, P. Amrolia, S. Stafford, K. Butler, C. Rivat, G. Wright, K. Somana, S. Ghorashian, D. Pinner, G. Ahsan, K. Gilmour, G. Lucchini, S. Inglott, W. Mifsud, R. Chiesa, K. S. Peggs, L. Chan, F. Farzeneh, A. J. Thrasher, A. Vora, M. Pule, P. Veys
Journal: Science Translational Medicine (2017)
Hospital-acquired complications in a randomized controlled clinical trial of a geriatric consultation team
Authors: P. M. Becker
Journal: JAMA (1987)

As part of a controlled clinical trial of a geriatric consultation team (GCT), we investigated whether a GCT could affect the incidence of hospital-acquired complications in elderly patients. One hundred eighty-five patients, aged 75 years and older, were randomized into an intervention (N = 92) and a control (N = 93) group. Members of the intervention group received a GCT consultation and were routinely followed up throughout their hospitalization. The incidence of hospital-acquired complications for the entire study population was 38%. The type and rate of hospital-acquired complications in the intervention and control groups were not significantly different. Functional status on admission and admission to the psychiatry service were predictive for the occurrence of a hospital-acquired complication. In a broadly selected population such as this, the intensity of care available through a GCT was unable to reduce the occurrence of hospital-acquired complications. However, since this is only one aspect of a GCT function, and others may be of great importance, such aspects, and more targeted populations, must be evaluated before final conclusions can be reached about GCT efficiency. (<i>JAMA</i>1987;257:2313-2317)
Medicine Stone
Authors: Jock Murray
Journal: Annals of Internal Medicine (2003)

Medical Writings: Book Notes4 March 2003Medicine StoneJock Murray, MDJock Murray, MDDalhousie Medical School, Halifax, Nova Scotia, Canada.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-138-5-200303040-00030 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Coulehan J. 108 pages. Santa Barbara, CA: Fithian Pr; 2002. ISBN 1564744051. Order phone 800-662-8351.Field of medicine: Medical humanities.Format: Softcover book.Audience: Physicians, the general public, and particularly those who are interested in the medical humanities or teach medicine and literature.Purpose: To capture in a moving, insightful, and sometimes jarring fashion the beauty, joys, frailty, and anguish of people's lives and bodies when they come into contact with medicine and the emotion and sensitivities evoked in the physicians who meet them.Content: The book has three parts: Medicine Stone, The Cherry Orchard, and The First Assent of ... Author, Article, and Disclosure InformationAffiliations: Dalhousie Medical School, Halifax, Nova Scotia, Canada. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 4 March 2003Volume 138, Issue 5Page: 444KeywordsDatabasesEmotionsForecastingFrailtyLibrariesMedical ethics, humanities, and educationSoftware tools ePublished: 4 March 2003 Issue Published: 4 March 2003 Copyright & PermissionsCopyright © 2003 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
American Journal of Diseases of Children, Chicago
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A Practical Medical Dictionary of Words used in Medicine with Their Derivation and Pronunciation, Including Dental, Veterinary, Chemical, Botanical, Electrical, Life Insurance and Other Special Terms; Anatomical Tables of the Titles in General Use, and Those Sanctioned by the Basle Anatomical Convention; Pharmaceutical Preparations, Official in the U. S. and British Pharmacopoeias and Contained in the National Formulary; Chemical and Therapeutic Information as to Mineral Springs of America and …
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue
Drugs and obesity
Journal: JAMA (1968)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Insect Bites
Authors: CLAUDE A. FRAZIER
Journal: Annals of Internal Medicine (1974)

Comments1 July 1974Insect BitesCLAUDE A. FRAZIER, M.D.CLAUDE A. FRAZIER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-81-1-134 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Again this year I am compiling case reports of allergic reactions to biting insects, such as mosquitoes, fleas, gnats, kissing bugs, bedbugs, chiggers, black flies, horseflies, sandflies, deerflies, and so forth. I am also interested in reactions to the imported and southern fire ants.I would like physicians to supply me with case reports of those patients who have had reactions to such insects. Include in your reports the type of reaction and complications, if any; the age, sex, and race of the patient; the site of the bite(s); the season of the year; the immediate symptoms;... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: CLAUDE A. FRAZIER, M.D.Affiliations: 4-C Doctors Park Asheville, North Carolina 28801 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 July 1974Volume 81, Issue 1Page: 134-134KeywordsAllergy and immunologyAntsFleasMosquitoesRacial and ethnic issues ePublished: 1 December 2008 Issue Published: 1 July 1974 PDF downloadLoading ...
Clinical activity of ERY001 (erythrocyte encapsulated l-asparaginase) and native l-asparaginase (L-ASP) in combination with COOPRALL regimen in phase III randomized trial in patients with relapsed acute lymphoblastic leukemia (ALL).
Authors: Yves Bertrand, Andre Baruchel, Xavier G. Thomas, Nicolas Blin, Emmanuelle Tavernier Tardy, Yves Perel, Norbert Vey, Virginie Gandemer, Victoria Cacheux, Francoise Mazingue, Emmanuel Raffoux, Genevieve Plat, Maryline Poiree, Jean-Louis Stephan, Anne Auvrignon, Dominique Plantaz, Isabelle Pellier, Cecile Bonin, Iman El-Hariry, Alina Ferster
Journal: Journal of Clinical Oncology (2015)

7004 Background: Asparaginase is a cornerstone in the treatment of ALL, but its utility is limited by toxicities including hypersensitivity. Clinical allergy is associated with inactivation of asparaginase by antibodies (A-Abs), which can also neutralize asparaginase without any clinical signs of hypersensitivity (silent inactivation). ERY001 improves pharmacokinetics, tolerability and maintain circulating asparaginase (ASPA) activity due to the protective barrier of the erythrocyte membrane. Methods: This open, randomized international Phase 3 study enrolled pts with relapsed ALL. The co-primary endpoints were the duration of ASPA activity > 100IU/L and the incidence of ASPA hypersensitivity during induction. Key secondary endpoints were complete remission (CR), minimal residual disease (MRD), event free survival (EFS) and overall survival (OS).The study was powered to detect 3-fold difference in the incidence of allergic reactions between treatments. Pts (n = 80), aged 1-55 years were randomized to ERY001 (150 IU/kg, n = 26 or L-ASP (10,000 IU/m², n = 28), or to ERY001-exp (prior allergy, n = 26). Results: In the non-allergic pts, ERY001 significantly reduced the incidence of ASPA hypersensitivity (0% vs 43%; p < 0.001). ASPA activity > 100 IU/l was 21 ±5 vs 9± 8 days in ERY001 and L-ASP, respectively (p < 0.001). The CR rate: ERY001 (65%, 95% CI: [51.6:89.8]) vs L-ASP (39%, 95% CI: [23.3:63.1]; p = 0.026). Allograft was successfully performed in 65% of ERY001 vs. 46% of L-ASP. The proportion of patients who achieved MRD < 10-3 in F1-F2/VANDA was 35% and 25% in ERY001, and L-ASP arms, respectively. At 12 mo, EFS rate was 65% and 49% in ERY001 and L-ASP arm, respectively. Treatment with ERY001 was well tolerated Conclusions: ERY001 provides an alternative option for patients with relapsed ALL, which is well tolerated and efficacious. Clinical trial information: NCT 01518517.